The HAB Pharma & Studies Corp represents a player in the domestic medicinal market. Founded in the late 1940s, the company has built a robust reputation for producing high-quality generic drugs and consistently contributes in ongoing research to advance patient well-being. Its offering features a therapeutic categories, indicating their commitment